- Ivabradine +12015 | First Faculty of Medicine
- Is the role of ivabradine clear?2013 | First Faculty of Medicine
- A present view on ivabradine in the therapy of cardiovascular diseases2017 | Third Faculty of Medicine
- Ivabradin, heart rate and cardiovascular risk. A commentary on the BEAUTIFUL trial2009 | First Faculty of Medicine
- Ivabradin - the first representant of new therapeutic group of bradin2005 | First Faculty of Medicine
- Ivabradine in the treatment of ischemic heart disease - results of the BEUTIFUL study2010 | First Faculty of Medicine
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | Faculty of Medicine in Pilsen
- Ivabradin2017 | First Faculty of Medicine
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | Central Library of Charles University
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Ivabradine for patients with stable coronary artery disease and left - ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial2008 | First Faculty of Medicine
- Ivabradin has beneficial effect on prognosis of patients with stable angina pectoris - subgroup analysis of the BEAUTIFUL study2009 | First Faculty of Medicine
- The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population2008 | First Faculty of Medicine
- Ivabradin v léčbě srdečního selhání2018 | First Faculty of Medicine
- Heart rate and cardiovascular risk: What does the BEAUTIFUL study say?2008 | Second Faculty of Medicine
- Ivabradine in stable coronary artery disease2014 | First Faculty of Medicine
- BEAUTIFUL Study. The effect of ivabradine on risk of cardiovascular events in patients with CAD and systolic dysfunction of left ventricle. Does slowing of heart rate improve prognosis of patients with CAD?2006 | First Faculty of Medicine
- Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension2020 | Faculty of Medicine in Hradec Králové
- Ivabradine does not Impair Anxiety-Like Behavior and Memory in Both Healthy and L-NAME-Induced Hypertensive Rats2018 | Faculty of Medicine in Hradec Králové
- Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension2018 | Faculty of Medicine in Hradec Králové
- Significance of pharmacological intervention for heart rate treating cardiovascular disease2012 | Third Faculty of Medicine
- What has the SIGNIFY trial shown?2015 | First Faculty of Medicine
- Ivabradine, Coronary Heart Disease, and Heart Failure: Time for Reappraisal2014 | First Faculty of Medicine
- Ivabradine in stable coronary artery disease without clinical heart failure2014 | First Faculty of Medicine
- Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol-induced myocardial injury2021 | Faculty of Medicine in Hradec Králové
- The role of heart rate in patients with coronary artery diseases2009 | First Faculty of Medicine
- Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension2016 | Faculty of Medicine in Hradec Králové
- Heart rate in modification of cardiovascular risk: focus on BEAUTIFUL trial2008 | First Faculty of Medicine
- Pharmacological therapy for chronic heart failure2018 | First Faculty of Medicine